Biotricity Free Cash Flow 2015-2023 | BTCY

Biotricity free cash flow from 2015 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Biotricity Annual Free Cash Flow
2023 -13.55
2022 -15.19
2021 -11.08
2020 -7.86
2019 -5.22
2018 -4.88
2017 -3.75
2016 -2.38
2015 -1.96
2015 -0.03
2015
2014 -0.01
2014
Biotricity Quarterly Free Cash Flow
2023-12-31 -5.53
2023-09-30 -4.22
2023-06-30 -1.83
2023-03-31 -13.55
2022-12-31 -11.67
2022-09-30 -8.49
2022-06-30 -4.04
2022-03-31 -15.19
2021-12-31 -10.44
2021-09-30 -5.92
2021-06-30 -2.68
2021-03-31 -11.08
2020-12-31 -7.50
2020-09-30 -4.53
2020-06-30 -2.39
2020-03-31 -7.86
2019-12-31 -4.91
2019-09-30 -2.79
2019-06-30 -1.33
2019-03-31 -5.22
2018-12-31 -4.06
2018-09-30 -2.67
2018-06-30
2018-03-31 -4.88
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2015-12-31
2015-09-30
2014-09-30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.011B $0.010B
Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $36.755B 20.18
Inspire Medical Systems (INSP) United States $4.712B 0.00
Axonics (AXNX) United States $3.441B 0.00
10x Genomics (TXG) United States $3.165B 0.00
IRhythm Technologies (IRTC) United States $3.092B 0.00
Hims & Hers Health (HIMS) United States $2.951B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.949B 0.00
Enovis (ENOV) United States $2.880B 21.34
Azenta (AZTA) United States $2.763B 155.30
Privia Health (PRVA) United States $2.154B 120.33
Schrodinger (SDGR) United States $1.690B 0.00
Omnicell (OMCL) United States $1.391B 48.06
Phreesia (PHR) United States $1.251B 0.00
Standard BioTools (LAB) United States $0.737B 0.00
Fulgent Genetics (FLGT) United States $0.668B 0.00
Definitive Healthcare (DH) United States $0.643B 0.00
Clover Health Investments (CLOV) United States $0.505B 0.00
Talkspace (TALK) United States $0.484B 0.00
Health Catalyst (HCAT) United States $0.404B 0.00
Pulmonx (LUNG) United States $0.346B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.303B 0.00
P3 Health Partners (PIII) United States $0.212B 0.00
Butterfly Network (BFLY) United States $0.207B 0.00
Outset Medical (OM) United States $0.181B 0.00
American Well (AMWL) United States $0.148B 0.00
TruBridge (TBRG) United States $0.132B 7.10
MSP Recovery (LIFW) United States $0.113B 0.00
111 (YI) China $0.110B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.073B 0.00
Future Health ESG (FHLT) United States $0.068B 0.00
SHL Telemedicine (SHLT) Israel $0.063B 0.00
EUDA Health Holdings (EUDA) Singapore $0.057B 0.00
Augmedix (AUGX) United States $0.056B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) China $0.053B 0.00
Movano (MOVE) United States $0.041B 0.00
Akili (AKLI) United States $0.035B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
CareCloud (CCLD) United States $0.030B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Cue Health (HLTH) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Syra Health (SYRA) United States $0.011B 0.00
Transgenomic (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00